Kane Biotech's latest marketcap:
As of 07/05/2025, Kane Biotech's market capitalization has reached $6.11 M. According to our data, Kane Biotech is the 42805th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 6.11 M |
| Revenue (ttm) | 1.7 M |
| Net Income (ttm) | 4.37 M |
| Shares Out | 0 |
| EPS (ttm) | 0.03 |
| Forward PE | 0.00 |
| Ex-Dividend Date | n/a |
| Earnings Date | 08/29/2025 |
Kane Biotech's yearly market capitalization.
| Date | Market Cap | Change (%) | Global Rank |
|---|---|---|---|
| 07/05/2025 | $6.11 M | -36.34% | 42805 |
| 12/31/2024 | $10.51 M | 31.63% | 46689 |
| 12/29/2023 | $7.99 M | -3.79% | 45031 |
| 12/30/2022 | $8.3 M | -40.97% | 43335 |
| 12/31/2021 | $14.06 M | 17.84% | 41382 |
| 12/31/2020 | $11.93 M | 8.89% | 38250 |
| 12/31/2019 | $10.96 M | 119.6% | 35654 |
| 12/31/2018 | $4.99 M | -17.77% | 34320 |
| 12/29/2017 | $6.07 M | 43.78% | 32860 |
| 12/29/2016 | $4.22 M | -0.77% | 30886 |
Company Profile
About Kane Biotech Inc.
Kane Biotech Inc. is a biotechnology company focused on the research, development, and commercialization of innovative technologies and products designed to prevent and remove microbial biofilms. The company operates in Canada and internationally, leveraging its proprietary technologies to address critical healthcare challenges.
Key Technologies
- coactiv+ Technology: An antimicrobial wound gel platform used in various medical applications.
- DispersinB Technology: A naturally occurring enzyme that targets bacterial biofilms, aiding in wound and otic infection treatments.
Product Portfolio
- Revyve: An antimicrobial wound gel designed for effective wound care.
- DermaKB Brand: Includes shampoos, shampoo bars, and scalp detoxifiers for dermatological health.
Pipeline Developments
- coactiv+ Antimicrobial Surgical Hydrogel: For surgical and acute wound care.
- coactiv+ Antimicrobial Wound Rinse: Designed for acute and chronic wounds.
- coactiv+ Antimicrobial Wound Gel Spray: Suitable for acute/chronic wounds and burns.
- DispersinB Hydrogel: Targeted at prosthetic joint infections.
Company Background
Founded in 2001, Kane Biotech Inc. is headquartered in Winnipeg, Canada, and continues to pioneer advancements in biofilm prevention and removal.
Frequently Asked Questions
-
What is Kane Biotech's (OTC-KNBIF) current market cap?As of 07/05/2025, Kane Biotech (including the parent company, if applicable) has an estimated market capitalization of $6.11 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Kane Biotech (OTC-KNBIF) rank globally by market cap?Kane Biotech global market capitalization ranking is approximately 42805 as of 07/05/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.